CD274 and neoplasm: In the cemiplimab plus chemotherapy group, there was a consistent relationship between ORR and baseline PD-L1 expression (Fig. 3c), with benefits versus placebo plus chemotherapy seen across all levels of baseline PD-L1 expression; there was also a clear association between continuous measure of changes in tumor size over time and baseline PD-L1 expression (Fig. 3d).